Iveda Solutions, Inc. annual report, FY2021

Iveda Solutions, Inc. — Form 10-K Summary

Reporting period: Fiscal year ended December 31, 2021. The filing is an annual report rather than a standalone quarterly report; “2021 Q4” corresponds to the year-end reporting period. Iveda provides AI video analytics, surveillance systems, IoT platforms, sensors, trackers, and smart-power solutions through its U.S. operations and Taiwan-based MEGAsys subsidiary.

Business Context and Reporting Period

  • Iveda’s business model combines hardware sales with recurring software and monitoring revenue. MEGAsys continues to execute project-based surveillance and integration contracts in Taiwan.
  • MEGAsys generated 93% of consolidated revenue in 2021, compared with 71% in 2020.
  • The company had 10 full-time U.S. employees and 25 full-time Taiwan employees at December 31, 2021.
  • Revenue was concentrated among Taiwan customers: Chunghwa Telecom represented 41% of 2021 revenue and Taiwan Stock Exchange represented 14%.

Financial Highlights

Metric20212020Change
Total revenue$1.918 million$1.484 millionUp 29%
Equipment sales$1.648 million$1.151 millionUp 43%
Service revenue$264,402$325,680Down 19%
Cost of revenue$1.086 million$991,558Up 9%
Gross profit$832,255$492,677Up 69%
Gross margin43%33%Improved 10 percentage points
Operating expenses$3.558 million$1.721 millionUp 107%
Loss from operations$(2.725) million$(1.229) millionLoss increased 122%
Net loss$(2.999) million$(1.602) millionLoss increased 87%
Basic and diluted loss per share$(0.04)$(0.03)More negative
Net cash used in operating activities$(1.972) million$(145,568)Higher cash use
Cash and cash equivalents$1.385 million$249,521Increased substantially

Financial Position, Debt and Liquidity

  • Total assets were $2.988 million at December 31, 2021, compared with $1.246 million at December 31, 2020.
  • Current assets were $2.676 million, including $1.385 million of cash, $492,752 of accounts receivable, and $344,654 of inventory.
  • Total current liabilities were $3.426 million, including $2.956 million of accounts and other payables, $300,000 due to related parties, $50,000 of short-term debt, and $120,284 of current long-term debt.
  • Long-term debt was $338,803, resulting in total reported short- and long-term debt of approximately $509,087, excluding amounts due to related parties.
  • Stockholders’ equity remained negative at $(777,279), although this improved from $(3.707) million in 2020.
  • Cash flow was dependent on financing. Financing activities provided $3.123 million in 2021, primarily from common-stock and warrant issuances, offsetting operating and investing cash usage.
  • The company states that it has limited liquidity and must raise additional capital or increase revenue to continue as a going concern. Approximately $4.0 million had been raised through the approved private financing round as of December 31, 2021, while the cash-flow statement reports $2.823 million of net common-stock proceeds during 2021.

Material Changes Versus the Prior Comparable Period

  • Revenue increased primarily because of additional long-term MEGAsys equipment contracts initiated during 2021.
  • Gross margin improved from 33% to 43%, principally because of the higher-margin MEGAsys contract mix.
  • Recurring service revenue declined from 22% to 14% of consolidated revenue, while equipment revenue increased from 78% to 86%.
  • Operating expenses more than doubled because of increased U.S. administrative, sales, technical-support, and IvedaAI research and development personnel, as well as professional costs associated with OTC Markets reporting and the Form 10-12G registration statement.
  • Stock-based compensation increased to $801,908 from $165,167, contributing to the higher operating expense burden.
  • Common shares outstanding increased to 77.3 million from 52.7 million, reflecting equity financing, debt conversions, option and warrant exercises, and other equity issuances.
  • Short-term debt declined from $865,988 to $50,000, while new long-term bank debt was reported at December 31, 2021.

Guidance, Outlook, Risks and Unusual Items

  • No specific revenue, earnings, margin, or cash-flow guidance was provided.
  • Management expects continued development of the Cerebro IoT platform and IvedaAI technology and intends to expand through service-provider, telecommunications, integrator, and reseller channels.
  • The independent auditor identified substantial doubt about the company’s ability to continue as a going concern because of recurring losses, accumulated deficits, and negative operating cash flow.
  • Management states that additional financing will be required. Future equity or debt financing could be unavailable, unfavorable, or materially dilutive.
  • Customer and geographic concentration is significant: 93% of revenue came from MEGAsys, two customers represented 55% of revenue, and Chunghwa Telecom represented 95% of accounts receivable at year-end.
  • COVID-19 reduced demand and delayed Taiwan projects. Management estimated revenue impacts of approximately $1.2 million in 2020 and $0.2 million in the first quarter of 2021, with improved demand during the last nine months of 2021.
  • Internal control over financial reporting was determined to be ineffective as of December 31, 2021 because of inadequate change-management controls for technology supporting financial reporting and insufficient SEC accounting and reporting staffing at MEGAsys. Remediation initiatives were planned for 2022.
  • The company has no currently owned patents and relies primarily on trademarks, copyrights, trade secrets, licenses, and confidentiality agreements.
  • Potential contingencies include $61,435 of exposure related to required after-project services in Taiwan contracts.
  • The company trades on the OTC market, has limited trading liquidity, does not pay dividends, and has substantial outstanding options and warrants that may create future dilution.
  • The filing contains inconsistent descriptions of accumulated losses: the balance sheet reports accumulated deficit of $41.361 million at December 31, 2021, while other narrative sections cite approximately $41 million, $31 million, or $38 million. The audited financial statements should control the reported amount.

Investor Verification Checklist

  • Verify the going-concern assessment, expected cash runway, and the timing and terms of required future financing.
  • Reconcile the approximately $4.0 million financing described in risk disclosures with the $2.823 million of net common-stock proceeds shown in the cash-flow statement.
  • Review the full debt, convertible-debt, related-party, option, and warrant schedules, including potential dilution from 7.15 million options and 6.98 million warrants outstanding at year-end.
  • Assess the sustainability and margins of MEGAsys project revenue versus the declining recurring-service revenue base.
  • Evaluate customer concentration, particularly Chunghwa Telecom’s 41% revenue contribution and 95% share of year-end accounts receivable.
  • Monitor remediation of the material weakness in internal control over financial reporting and the planned addition of MEGAsys accounting personnel.
  • Confirm the correct accumulated deficit and accumulated-loss figures in the audited financial statements and subsequent filings.